Third-party Logistics Market to Reflect Steadfast Expansion During 2021-2028: Grand View Research Inc.

 Third-party Logistics Market Growth & Trends

The global third-party logistics market size is expected to reach USD 1,691.86 billion by 2028, registering a CAGR of 8.5% from 2021 to 2028, according to a new report by Grand View Research, Inc. The advent of new technologies is changing the 3PL industry dynamics. The advanced data collection capabilities, warehouse automation, and digitalization of the entire supply chain are enabling companies to adopt a consistent innovative, customer-centric, and agile approach. As a result, 3PL companies are providing technologically driven services by investing in block-chain solutions, mobile technologies, and 3PL software to gain a competitive advantage in a fiercely competitive marketplace.

The Internet of Things (IoT) and cloud-based logistics management solution turn the data into actionable value-added information, which can shape the strategic decision-making process and increase productivity. Some of the capital-intensive organizations are increasing their Information Technology (IT) spending and are using predictive analytics for supply chain enhancement. For instance, C.H. Robinson Worldwide, Inc. is using Artificial Intelligence (AI) technology to analyze customer data and get notified about extreme weather conditions or traffic disruption.

Logistics automation is expected to play a vital role in the growth of the market. The use of robots in warehouses and unloading docks helps streamline order fulfillment services. The use of Automated Guided Vehicle (AGV) can help to lessen human errors, resolve material handling issues, ensure movement of high-volume goods, and increase accuracy and repeatability. To deliver immediate value and long-term returns, companies are widely accepting logistics automation.

The value-added logistics services are expected to witness the highest growth rate over the forecast period. The 3PL companies are offering comprehensive logistics services to ensure their competitiveness of the business. Shippers are reducing their operational costs by shifting their focus from transportation and back-office functions, such as warehousing, order taking & picking process, kitting & final assembly, product localization, and labeling. Thus, the value-added logistics services are becoming a boon for the shippers to mitigate inventory and transportation costs.

Request a free sample copy or view report summary: Third-party Logistics Market Report

Third-party Logistics Market Highlights

• The market is anticipated to witness substantial growth during the forecast period due to the development of logistics infrastructure in the Asia and Middle East regions, growth of the global e-commerce sector, and the development of new technologies
• The value-added logistics services segment is expected to register the highest CAGR over the forecast period
• The market players are focusing on providing value-added services to unveil their unique capabilities and offer enhanced customer experience, facilitating the segment growth
• The retail end use segment is expected to register the highest CAGR over the forecast period owing to benefits offered by retail stores, such as same-day delivery
• The roadways segment held the largest share in 2020 owing to the growing public-private partnerships model and increased emphasis on logistics infrastructure
• Globalization, along with sustainable economic growth, is expected to drive the growth of the airways logistics mode over the forecast period
• Asia Pacific is anticipated to register the highest CAGR of over 10.0% from 2021 to 2028 owing to the growing transport infrastructure and effective transit of freight and goods in emerging countries

Access Press Release@ https://www.grandviewresearch.com/press-release/global-third-party-logistics-market

Third-party Logistics Market Segmentation

Grand View Research has segmented the global Third-party Logistics (3PL) market on the basis of service, transport, end use, and region:

3PL Service Outlook (Revenue, USD Billion, 2016 - 2028)

• Dedicated Contract Carriage (DCC)/Freight Forwarding
• Domestic Transportation Management (DTM)
• International Transportation Management (ITM)
• Warehousing &Distribution (W&D)
• Value-Added Logistics Services (VALs)

3PL Transport Outlook (Revenue, USD Billion, 2016 - 2028)

• Roadways
• Railways
• Waterways
• Airways

3PL End use Outlook (Revenue, USD Billion, 2016 - 2028)

• Manufacturing
• Retail
• Healthcare
• Automotive
• Others

3PL Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
• MEA

List of Key Players of Third-party Logistics (3PL) Market

• BDP International
• H. Robinson Worldwide, Inc.
• CEVA Logistics
• DSV
• DB Schenker Logistics
• FedEx
• B. Hunt Transport, Inc.
• Kuehne + Nagel
• Nippon Express
• United Parcel Service of America, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Thermoform Packaging Market Trends, Growth Prospects To 2028: Grand View Research Inc.

 Thermoform Packaging Market Growth & Trends

The global thermoform packaging market size is expected to reach USD 64.21 billion by 2028 registering a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. High adoption of products, such as blisters & clamshell packaging, containers, and trays & lids, by the end-user industries including food & beverages, electronics, pharmaceuticals, and personal care & cosmetics, coupled with increased penetration of organized and e-retail, have been driving the market from the past several years.

In thermoforming, the thermoplastic sheet is heated up to its pliable temperature and then placed over a mold until it cools and takes shape of the mold. A thin-gauge sheet, which is usually less than 0.060 inches, is mainly used to produce rigid disposable products, such as trays, bowls, containers, plates, and others. Thermoforming plastic molding process offers several advantages over injection molding including lower tooling cost, less wastage of material, and less per-unit cost for short-run production, owing to which the end-use industries, primarily food & beverages, mainly prefer thermoformed packaging products.

The packaged food industry, wherein thermoformed trays, containers, and tubs are widely used for the packaging of meat, fruits, eggs, and ready meals, is rapidly expanding across the world. Increasing urbanization and penetration of retail networks coupled with changing lifestyles are majorly contributing to the growth of the global packaged food industry, and thereby augmenting the product demand. Moreover, the rising micro-family structure, which creates demand for single-serve packaging, is expected to favor the growth of the market.

Global electronic manufacturers are mainly focusing on the development of compact devices, as they are easy to carry, which, in turn, is expected to benefit the usage of products such as trays and containers. However, electronics and food manufacturers are gradually shifting towards sustainable products, such as molded pulp trays. This increasing availability of alternative solutions coupled with the growing awareness regarding sustainability among consumers is likely to limit the market growth over the forecast period.

Due to their effectiveness, thermoformed blisters are widely utilized for the packaging of pharmaceutical solid oral dose products, such as capsules and tablets. These benefits of blisters along with their low cost and ease of usage are attracting North American pharmaceutical companies to switch from the traditional bottle packaging for solid oral doses, thereby supporting market growth. Moreover, the rising prevalence of chronic diseases coupled with the growing aging population has been driving the global pharmaceutical industry, which in turn, is expected to increase the product application scope in the pharmaceutical industry.

Asia Pacific is estimated to be the largest as well as the fastest-growing regional market from 2021 to 2028. This growth is credited to the rapid penetration of organized and e-retail sectors coupled with increased spending on processed food and consumer products, which drive the product demand in the regional market. Market participants across the globe compete on the basis of product differentiation and services offered. Pactiv LLC emerged as the market leader in 2020 on account of its wide-scale product offerings, especially for food & beverage applications.

Request a free sample copy or view report summary: Thermoform Packaging Market Report

Thermoform Packaging Market Report Highlights

• The food & beverage end-user industry segment led the global market accounting for the largest revenue share of over 51% in 2020
• The segment will grow further at a steady CAGR from 2021 to 2028 owing to the rising adoption of thermoformed trays, containers, and blisters by packaged food manufacturers and meat processors
• The pharmaceutical end-user industry segment accounted for a significant revenue share in 2020 and is estimated to expand further at the fastest CAGR from 2021 to 2028
• This growth can be attributed to the extensive incorporation of thermoform blisters by the pharmaceutical companies for the unit dose packaging
• The containers product segment accounted for the highest revenue share of over 26% in 2020 owing to high product adoption in the packaging of ready meals and processed food & beverages by the food processing companies
• PET led the material segment with a revenue share of 45.0% in 2020 and is expected to witness significant growth from 2021 to 2028
• Low cost, versatility in molding, transparency, and ease of recycling offered by PET materials are the few factors responsible for the segment growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-thermoform-packaging-market

Thermoform Packaging Market Segmentation

Grand View Research has segmented the global thermoform packaging market on the basis of material, product type, end-user industry, and region:

Thermoform Packaging Material Outlook (Revenue, USD Million, 2017 - 2028)

• PET
• PVC
• PS
• PP
• PE
• Others

Thermoform Packaging Product Type Outlook (Revenue, USD Million, 2017 - 2028)

• Blister
• Clamshell
• Skin Packaging
• Trays & Lids
• Containers
• Others

Thermoform Packaging End-user Industry Outlook (Revenue, USD Million, 2017 - 2028)

• Food & Beverage
• Personal Care & Cosmetics
• Pharmaceuticals
• Electronics
• Homecare
• Others

Thermoform Packaging Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Thermoform Packaging Market

• Amcor
• Sonoco Products Company
• Placon Corp.
• Display Pack, Inc.
• Pactiv LLC
• Dart Container Corp.
• Constantia
• Tray-Pak Corp.
• D&W Fine Pack
• Lacerta Group, Inc.
• RPC Group Plc
• Silgan Holdings, Inc.
• Sinclair & Rush, Inc.
• Rompa Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Robots Market Size Projected to Rise Lucratively during 2021 to 2028: Grand View Research Inc.

 Surgical Robots Market Growth & Trends

The global surgical robots market size is expected to reach USD 14.04 billion by 2028 and is expected to expand at a CAGR of 21.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing awareness and adoption of minimally invasive surgeries due to the potential benefits provided by them is impacting the growth positively. Furthermore, the increasing penetration of international players is further bolstering revenue growth over the forecast period.

Furthermore, rising acceptance for robotic procedures and laparoscopic procedures, technological advancements in medical imaging, and increasing prevalence of lung cancer, tumors, spine disorders, and other conditions are some of the major factors anticipated to boost the adoption and acceptance of surgical robots over the forecast period. However, the restricted rate of adoption of surgical robots in underdeveloped and developing economies owing to untrained doctors and limited healthcare spending may hinder the growth of the market.

Based on application, the market is segmented into neurology, orthopedics, urology, gynecology, and others. In 2020, the others segment accounted for the highest revenue share. This segment mainly includes the usage of surgical robots in laparoscopy, oncology, and various other general surgeries. This growth is attributed to the increasing demand for minimally invasive laparoscopic surgeries and the growing usage of surgical robots in cancer. In addition, reduction in limitations associated with traditional surgery procedures and enhancement in delivering successful outcomes through the utilization of robotic technologies is further fueling the adoption and growth.

North America dominated the market with a revenue share of 51.3% in 2020 owing to the significant presence of international players along with the lineup of many products for FDA clearance, ongoing developments in robotics, and the demand for minimally invasive surgeries to reduce the post-operative period. Furthermore, R&D initiatives about ergonomically designed workstations to improve learning curves and speed up clinical adoption in the region, coupled with improvements in miniaturization of instruments, are the other factors boosting the growth in the region.

Request a free sample copy or view report summary: Surgical Robots Market Report 

Surgical Robots Market Report Highlights

• The growing awareness about minimally invasive surgeries and their rising adoption due to the potential benefits are the key factors fueling the market growth
• The others segment dominated the global market in 2020, owing to increasing demand for minimally invasive laparoscopic surgeries and growing usage of surgical robots in cancer
• The North America region dominated the global market for surgical robots with a revenue share of 51.3% in 2020, owing to the significant presence of international players along with the lineup of many products for FDA clearance, ongoing developments in robotics, and the demand for minimally invasive surgeries to reduce the post-operative period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-surgical-robot-market

Surgical Robots Market Segmentation

Grand View Research has segmented the global surgical robots market based on application and region:

Surgical Robot Application Outlook (Revenue, USD Million, 2016 - 2028)

• Orthopedics
• Neurology
• Urology
• Gynecology
• Others

Surgical Robot Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
• Asia-Pacific
  • Australia
  • China
  • Japan
  • South Korea
  • India
  • Singapore
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Surgical Robots Market

• Medrobotics Corporation
• Smith and Nephew
• Transenterix, Inc
• Intuitive Surgical
• Renishaw, plc
• Medtronic
• Stryker Corporation
• Zimmer Biomet
• Think Surgical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Molded Pulp Packaging Market Poised to Expand at a Robust Pace Over 2028: Grand View Research Inc.

 Molded Pulp Packaging Market Growth & Trends

The global molded pulp packaging market size is expected to reach USD 6.1 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% over the forecast period. Growing demand for eco-friendly sustainable packaging from the end-user segments owing to growing awareness regarding the adverse effects of plastic pollution is expected to be the key driver for the market.

The Covid-19 pandemic has benefitted the molded pulp packaging owing to increased demand for eggs from the retail segment. In addition, increasing demand for home deliveries of fresh food, vegetables, and other grocery items owing to restrictions on the movement of the public also supported the market growth. However, shortages of raw material owing to supply chain disruption have increased the prices of the packaging products.

Molded pulp packaging usage was limited to the transportation and distribution of eggs but owing to increased demand for recyclable, eco-friendly packaging, the penetration of these products in electronics, healthcare, and other industrial applications is also on the rise, which is expected to drive the market over the forecast period.

Molded pulp products are made of pulp obtained from virgin wood, discarded corrugated & folding boxes, recovered or wastepaper, and other sources. The aesthetic appeal and geometry of molded pulp products are not consistent when compared with plastic products. whereas plastic molded products offer excellent finishing & product appeal and shape consistency. Rapid development in bioplastic and biodegradable plastics is expected to create challenges for the market players.

The industry players are adopting several strategies including mergers & acquisitions, joint ventures, and partnership agreements to increase the customer base and individual market share. For instance, in January 2020, Sonoco Products Company acquired Plastique Holdings, Ltd. and Thermoform Engineered Quality LLC, together known as TEQ, a manufacturer of thermoformed packaging products. It was acquired from ESCO Technologies, Inc. for an amount of USD 187 million. This acquisition has further widened the product offerings from Sonoco Products Company.

Request a free sample copy or view report summary: Molded Pulp Packaging Market Report

Molded Pulp Packaging Market Report Highlights

• The wood pulp segment dominated the market in 2020 due to the abundant availability of virgin wood and wastepaper at a lower cost
• The transfer type segment accounted for the highest revenue share in 2020 owing to the high penetration of transfer molded pulp products, such as clamshells and trays, for fruits and eggs packaging
• Trays emerged as dominating product segment in 2020 on account of high demand for transport of fragile products including glass beverage bottles, wine bottles, eggs, etc. due to their easy availability, low cost, and good shock absorption capabilities
• The electronics end-use segment is anticipated to register the fastest CAGR over the forecast period
• Several electronic products, such as modems, set-up boxes, refrigerators, inverters, and printers, are packaged using molded pulp packaging products, such as end caps as they protect electronic devices during storage and transportation
• New product developments coupled with mergers & acquisitions, and capacity expansions are some of the key strategies adopted by market participants
• For instance, in December 2019, Huhtamaki launched a packaging product line called Future Smart Duo Fiber Lid suitable for cold and hot beverages. It is a sustainable solution produced using a mixture of bagasse and wood fibers

Access Press Release@ https://www.grandviewresearch.com/press-release/global-molded-pulp-packaging-market

Molded Pulp Packaging Market Segmentation

Grand View Research has segmented the global molded pulp packaging market on the basis of source, molded type, product, application, and region:

Molded Pulp Packaging Source Outlook (Revenue, USD Million, 2017 - 2028)

• Wood Pulp
• Non-wood Pulp

Molded Pulp Packaging Molded Type Outlook (Revenue, USD Million, 2017 - 2028)

• Thick Wall
• Transfer
• Thermoformed
• Processed

Molded Pulp Packaging Product Outlook (Revenue, USD Million, 2017 - 2028)

• Trays
• End Caps
• Bowls & Cups
• Clamshells
• Plates
• Others

Molded Pulp Packaging Application Outlook (Revenue, USD Million, 2017 - 2028)

• Food Packaging
• Food Service
• Electronics
• Healthcare
• Industrial
• Others

Molded Pulp Packaging Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • Saudi Arabia

List of Key Players of Molded Pulp Packaging Market

• Brodrene Hartmann A/S
• Huhtamako Oyj
• UFP Technologies, Inc.
• Thermoform Engineered Quality LLC
• Genpak, LLC
• Eco-Products, Inc.
• Fabri-Kal
• Sabert Corp.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Viral Vectors And Plasmid DNA Manufacturing Market to Record an Exponential CAGR by 2028

 Viral Vectors And Plasmid DNA Manufacturing Market Growth & Trends

The global viral vectors and plasmid DNA manufacturing market size is expected to reach USD 8.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 18.8% from 2021 to 2028. The robust pipeline for gene therapies and viral-vector-based vaccines has primarily driven the market.

Amidst the COVID-19 pandemic, the demand for viral vectors has rapidly increased especially in vaccinology. This led to expanding manufacturing capabilities by operating players to meet the growing demand. The application of these vectors in vaccine development has witnessed significant growth in 2020.

Also, an increase in the number of gene therapy-based discovery programs initiated by biotechnology and pharmaceutical companies is expected to drive the demand for scalable production of gene therapy vectors. Owing to this, several private and public agencies are providing funds to accelerate advancements in the manufacturing processes for viral vectors.

Besides, the implementation of single-use technology can lead to significant savings in capital, operating costs, materials, and labor. The use of this equipment will enhance efficiency and improve flexibility, leading to high yields of the final product. Thus, advancements in single-use technology directly impact revenue growth in this space.

Request a free sample copy or view report summary: Viral Vectors And Plasmid DNA Manufacturing Market Report

Viral Vectors And Plasmid DNA Manufacturing Market Report Highlights

• The Adeno Associated Virus (AAV) segment accounted for the significant revenue share in 2020. High usage and promising results in gene therapy clinical trials have boosted its adoption
• Moreover, several biopharma companies are offering their viral vector platform for the development of AAV-based gene therapy products, thereby driving the segment
• The downstream processing segment dominated the market in terms of revenue share. This can be attributed to the availability of advanced purification products
• Owing to the rising demand for cost-effective and scalable manufacturing processes, companies are involved in the development of the upstream cell culture processes
• This is anticipated to result in the notable growth of the upstream processing segment
• The vaccinology segment dominated the market in terms of revenue share in 2020
• The SARS-COV-2 pandemic has supplemented the use of vectors in this segment
• With the active engagement of the research community in the R&D of advanced therapies, research institutes captured the maximum revenue share in the market
• The initiation of several R&D programs by pharmaceutical and biopharmaceutical companies to combat the COVID-19 crisis would further propel market growth
• A rapidly growing pipeline of advanced therapy products for various cancer types has led to lucrative revenue generation in the cancer segment
• North America maintained its dominance in 2020 owing to the high number of entities engaged in offering products and services for viral vector manufacturing in the U.S.
• Furthermore, the remarkable success of viral vector-based Kymriah, Yescarta, and ZOLGENSMA in the U.S. has also contributed to regional dominance
• In Asia Pacific, the market is projected to witness the fastest growth rate owing to industrialization and clinical transformation of gene therapy in the region
• Companies continue to make focused attempts to expand their manufacturing facilities as well as service portfolio to maintain their market presence

Access Press Release@ https://www.grandviewresearch.com/press-release/global-viral-vector-plasmid-dna-manufacturing-market

Viral Vectors And Plasmid DNA Manufacturing Market Segmentation

Grand View Research has segmented the global viral vectors and plasmid DNA manufacturing market on the basis of vector type, workflow, application, end use, disease, and region:

Viral Vectors & Plasmid DNA Manufacturing Vector Type Outlook (Revenue, USD Million, 2017 - 2028)

• Adeno Associated Virus (AAV)
• Lentivirus
• Adenovirus
• Retrovirus
• Plasmid DNA
• Others

Viral Vectors & Plasmid DNA Manufacturing Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Upstream Processing
  • Vector Amplification & Expansion
  • Vector Recovery/Harvesting
• Downstream Processing
  • Purification
  • Fill-finish

Viral Vectors & Plasmid DNA Manufacturing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Antisense & RNAi
• Gene Therapy
• Cell Therapy
• Vaccinology
• Research Applications

Viral Vectors & Plasmid DNA Manufacturing End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes

Viral Vectors & Plasmid DNA Manufacturing Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Cancer
• Genetic Disorders
• Infectious Diseases
• Others

Viral Vectors & Plasmid DNA Manufacturing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Viral Vectors And Plasmid DNA Manufacturing Market

• Merck KGaA
• Lonza
• FUJIFILM Diosynth Biotechnologies
• Cobra Biologics
• Thermo Fisher Scientific
• Waisman Biomanufacturing
• Genezen laboratories
• YPOSKESI
• Advanced BioScience Laboratories, Inc. (ABL)
• Novasep Holdings S.A.S.
• Orgenesis Biotech Israel Ltd
• Vigene Biosciences Inc.
• General electric company (GE Healthcare)
• pharmaceuticals GMBH
• Batavia Biosciences
• Biovion Oy
• Wuxi Apptec Co Ltd
• VGXI Inc.
• Catalent Inc.
• Miltenyi Biotec GmbH
• SIRION Biotech GmbH
• Virovek Incorporation
• BioNTech IMFS GmbH
• VIVEbiotech S.L.
• Creative Biogene
• Vibalogics BmbH
• Takara Bio Inc.
• Cell and Gene Therapy Catapult Bluebird Bio Inc.
• Addgene Inc.
• Aldevron LLC
• Astellas Pharma Inc.
• BioMarin Pharmaceutical
• RegenxBio, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Disposable Endoscopes Market: Advanced Technologies and Growth Opportunities Worldwide By 2028

 Disposable Endoscopes Market Growth & Trends

The global disposable endoscopes market size is expected to reach USD 5.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rise in demand for single-use endoscopes for eliminating the risk of device-related infection is a major parameter driving the market. There is a rise in concern over device-related infection globally. For instance, nearly 350 patients from 41 medical facilities were infected by or exposed to contaminated gastroscopes in 2016, according to the U.S. FDA in 2016. Moreover, the American Journal of Infection Control detected microbial growth in 71.0% of the endoscope samples collected for research from three U.S. hospitals in 2018. Thus, increasing cases of hospital-acquired infections are driving the market growth. Moreover, there is a growing demand for reusable bronchoscopes as reusable contaminated bronchoscopes can put COVID-19 patients at risk.

Disposable endoscopes offer benefits such as reduction of costs of cleaning supplies, repairs, and maintenance. It also eliminates the long-term service contracts for endoscopes. The Cost-effectiveness of disposable endoscopes over reusable endoscopes is driving the market growth potential. Rise in prevalence of target-based diseases including ENT, neurological, cancer, GI disorders, and others along with the growing geriatric population is supporting the growth of the market.

Market players are investing in the development of medical devices including disposable bronchoscopes, disposable arthroscopes, and disposable gastroscopes. In addition, product approvals and launches are supporting the growth of the market. For instance, in July 2020, Ambu, a medical device manufacturer received a 510(k) clearance from the U.S. FDA clearance for its single-use duodenoscopes. The device includes single-use scope and a reusable processor. Moreover, the company launched Ambu aScope 4 Cysto, a single-use cystoscope. The cystoscope eliminates the repairing and reprocessing time of the urologist.

Request a free sample copy or view report summary: Disposable Endoscopes Market Report

Disposable Endoscopes Market Report Highlights

• Bronchoscopy emerged as the leading type segment in 2020 and accounted for the largest revenue share of 29.9% in the market
• The hospitals segment dominated the market and accounted for the largest revenue share in 2020, whereas the clinics segment is projected to expand at the fastest CAGR during the forecast period
• North America dominated the market and accounted for the largest revenue share of 42.1% in 2020, whereas Asia Pacific is projected to expand at the fastest CAGR during the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-disposable-endoscopes-market

Disposable Endoscopes Market Segmentation

Grand View Research has segmented the global disposable endoscopes market on the basis of application, end-use, and region:

Disposable Endoscopes Application Outlook (Revenue, USD Million, 2016 - 2028)

• Bronchoscopy
• Urologic endoscopy
• Arthroscopy
• GI endoscopy
• ENT endoscopy
• Others

Disposable Endoscopes End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals 
• Clinics
• Diagnostics Centers

Disposable Endoscopes Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Disposable Endoscopes Market

• Ambu A/S
• Prosurg Inc. (Neoscape, Inc.)
• AirStrip Technologies
• Boston Scientific Corporation
• Parburch Medical
• OBP Medical Corporation
• Welch Allyn (Hill-Rom Services Inc.)
• Allscripts Healthcare Solutions
• Flexicare Medical Limited
• Timesco Healthcare Ltd.
• Sunmed

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Printing Market to Witness a Pronounce Growth During 2021 – 2028: Grand View Research Inc.

 3D Printing Market Growth & Trends

The global 3D printing market size is estimated to reach USD 62.79 billion by 2028, according to the new report by Grand View Research, Inc. The market is expected to witness a CAGR of 21.0% from 2021 to 2028. 3D Printing (3DP) is also referred to as Additive Manufacturing (AM), as it involves successive addition of layers of materials in various 2D shapes using an additive process. These layered 2D shapes build upon one another to form a three-dimensional object. The process is different from the subtractive method of production, which begins with a block of material and the unnecessary material is ground out to obtain the desired object.

3D printing is widely adopted in the industrial sector owing to the growing need for enhanced product manufacturing and a shorter time to market. The industrial vertical happens to be the most significant adopter of the 3D printing technology and eventually leading to the highest market share of 3D printers for industrial applications over the forecast period. Additive manufacturing is anticipated to evolve over the forecast period.

3D printing continues to gain popularity among hobbyists and innovators. While individuals are using 3D printing for domestic and personal purposes, universities and educational institutes are using 3D printing for conducting technical training. The market is subject to witness a considerable economical appearance rather than being just a labor-intensive industrial manufacturing technique. Particularly in developing economies, such as Brazil, South Africa, and India, machining shops have managed to adopt alternative business models by installing 3D printers and offer related services, such as 3D printing materials, filaments, 3D modeling, and 3D printer software.

Based on application, the market has been segmented further into prototyping, tooling, and functional parts. Apart from the industrial vertical, the automotive, healthcare, and aerospace and defense verticals are among the leading adopters of 3D printing technology. Incumbents of these verticals have an emphasis on accuracy, enhanced product designing, reliability, shorter time to market, and economical production processes. Given that additive manufacturing possess can offer all these benefits, the adoption of three-dimensional printers by the automotive, healthcare, and aerospace and defense verticals is expected to gain traction over the forecast period.

The 3D printing and related technologies are evolving continuously in line with the intensive R&D activities being undertaken and the aggressive investments being made by the private sector as well as the public sector. Government funding and encouraging initiatives being undertaken in developed economies are prompting manufacturers to pursue improvements in technology and the adoption of new technologies.

North America accounted for the largest market share of more than 35% in 2020 as a result of the extensive adoption of 3D printers for 3D designing, 3D modeling, and 3D manufacturing in several industries. On the other hand, the Asia Pacific region has emerged as a manufacturing hub owing to an expanding consumer base as well as the continued foreign investments happening in the region. Hence, the Asia Pacific regional market is expected to witness remarkable growth over the forecast period.

3D printing technology happens to be a capital-intensive technology. At the same time, manufacturers are holding to their misconception about prototyping rather than realizing the advantages associated with 3D printing. Moreover, the market lacks the standard process controls and a skilled workforce required for 3D printing. These are some of the factors that are expected to restrain the market growth. However, government initiatives aimed at increasing awareness and promoting the benefits of adopting 3D printers are expected to help in countering the market restraints.

Request a free sample copy or view report summary: 3D Printing Market Report

3D Printing Market Report Highlights

• 3D printing technology is gaining traction owing to the ability of the technology to offer accurate and rapid prototyping and optimize the time to market
• Increasing adoption of 3D printers in the healthcare, automotive, and consumer electronics verticals is likely to drive the market growth significantly
• Demand for desktop 3D printers is expected to increase over the forecast period, as 3D printing is gaining popularity among hobbyists for domestic, household, and personal usage as well as in the education sector for training purposes
• The prototyping segment dominated the market in 2020 and is expected to expand its market share to more than 55% by 2028
• The polymer segment contributed to almost half of the entire industry share. However, the metal segment is expected to dominate the market in the next seven years. This is attributed to the increasing demand for metal 3D printing from industrial verticals such as automotive and aerospace and defense
• The desktop 3D printing segment, which has been segmented further into educational purpose, fashion and jewelry, objects, dental, food, and others, is expected to adopt the 3D printing technique aggressively over the forecast period
• The Asia Pacific regional market, which is emerging as a manufacturing hub for several industry verticals, is anticipated to grow significantly as the continued urbanization triggers the need for infrastructure and prompts the automotive, consumer electronics, aerospace and defense, and healthcare verticals to adopt 3D printing, particularly in countries, including China, Japan, and South Korea

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-printing-market

3D Printing Market Segmentation

Grand View Research has segmented the global 3D printing market based on component, printer type, technology, software, application, vertical, material, and region:

3D Printing Component Outlook (Revenue, USD Million, 2017 - 2028)

• Hardware
• Software
• Services

3D Printing Printer Type Outlook (Revenue, USD Million, 2017 - 2028)

• Desktop 3D Printer
• Industrial 3D Printer

3D Printing Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Stereolithography
• Fused Deposition Modelling
• Selective Laser Sintering
• Direct Metal Laser Sintering
• Polyjet Printing
• Inkjet printing
• Electron Beam Melting
• Laser Metal Deposition
• Digital Light Processing
• Laminated Object Manufacturing
• Others

3D Printing Software Outlook (Revenue, USD Million, 2017 - 2028)

• Design Software
• Inspection Software
• Printer Software
• Scanning Software

3D Printing Application Outlook (Revenue, USD Million, 2017 - 2028)

• Prototyping
• Tooling
• Functional Parts

3D Printing Vertical Outlook (Revenue, USD Million, 2017 - 2028)

• Industrial 3D Printing
  • Automotive
  • Aerospace & Defense
  • Healthcare
  • Consumer Electronics
  • Industrial
  • Power & Energy
  • Others
• Desktop 3D Printing
  • Educational Purpose
  • Fashion & Jewelry
  • Objects
  • Dental
  • Food
  • Others

3D Printing Material Outlook (Revenue, USD Million, 2017 - 2028)

• Polymer
• Metal
• Ceramic

3D Printing Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
• South America
  • Brazil
• Middle East & Africa

List of Key Players in the 3D Printing Market

• Stratasys Ltd.
• 3D Systems, Inc.
• 3D Ceram
• GE Additive
• HP Inc.
• Tiertime
• EnvisionTec, Inc.
• Dassault Systemes

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

COVID-19 Clinical Trials Market Pegged For Strong Growth During 2020-2027: Grand View Research Inc.

 COVID-19 Clinical Trials Market Growth & Trends

The global COVID-19 clinical trials market size is expected to reach USD 9.9 billion by 2027, registering a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. An increasing number of deaths due to coronavirus is creating a need to develop effective treatments, thereby boosting the market growth. Also, the underlying economic profits for first movers are encouraging pharmaceutical players to invest in clinical trial studies for COVID-19.

The current pandemic poses an acute health risk to the entire population. A key to successfully fighting COVID-19 lies in clinical research. At present, almost all the major research-based pharmaceutical companies, many other biotechnology and pharmaceutical companies, as well as research institutes are engaged in a race to develop an effective treatment against coronavirus. There are currently 661 unique compounds in development against COVID-19, of which 292 are drugs, 173 are vaccines and 196 are antivirals.

The regulators in the U.S. and Europe also offer various options for action and procedural facilitation to enable faster access to effective vaccines and drugs to combat the pandemic. In March 2020, the Solidarity Trial-an international clinical trial by the World Health Organization (WHO)-was launched to find effective treatment against COVID-19. In May 2020, WHO also announced an international alliance for developing various candidate vaccines to stop the spread of coronavirus disease, calling this effort the Solidarity trial for vaccines.

The current scenario across the globe and the need to come up with treatment options has also led to the fast-track of clinical trials. Hence, in March 2020, the Food and Drug Administration (FDA) launched a Coronavirus Treatment Acceleration Program (CTAP) for the likely therapies to accelerate the development of the treatment for the pandemic caused by a coronavirus. Recently in May 2020, the U.S. FDA granted fast track title to Moderna’s mRNA vaccine candidate, mRNA-1273, to protect against COVID-19.

Request a free sample copy or view report summary: COVID-19 Clinical Trials Market Report

COVID-19 Clinical Trials Market Report Highlights

• Phase II COVID-19 clinical trials dominated the market with a share of 35.0% in 2020. This is attributed to the maximum number of products currently in development.
• The vaccines segment accounted for the largest share of 77.1% in 2020 owing to the increasing investments towards it.
• Europe held 46.8% of the market share in 2020. Favorable government initiatives such as the UK’s “ACCORD” clinical trial program are contributing to market growth.
• The Asia Pacific region is projected to witness the fastest CAGR of 11.8% during the forecast period as the increasing number of biotechnology firms are looking at the region for their COVID-19 trials to take advantage of the large patient pool and fast-track procedures.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-clinical-trials-market

COVID-19 Clinical Trials Market Segmentation

Grand View Research has segmented the global COVID-19 clinical trials market based on phase, product, and region:

COVID-19 Clinical Trials Market Phase Outlook (Revenue, USD Million, 2016 - 2027)

• Phase I
• Phase II
• Phase III
• Phase IV
• Others

COVID-19 Clinical Trials Market Product Outlook (Revenue, USD Million, 2016 - 2027)

• Therapeutics
• Vaccines

COVID-19 Clinical Trials Market Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • The U.S.
  • Canada
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• The Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of COVID-19 Clinical Trials Market

• Moderna, Inc.
• GlaxoSmithKline plc
• Pfizer Inc.
• Johnson & Johnson
• Gilead Sciences Inc.
• INOVIO Pharmaceuticals
• AbbVie Inc.
• BioNTech SE
• Novavax
• Takeda

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Augmented Reality & Virtual Reality In Healthcare Market Set to Witness an Uptick during 2021 to 2028: Grand View Research Inc.

 Augmented Reality & Virtual Reality In Healthcare Market Growth & Trends

The global augmented reality & virtual reality in healthcare market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 27.2% from 2021 to 2028. Increasing advancements and digital disruptions in the healthcare system, rising healthcare expenditure, and the rising need for efficient and innovative solutions to enhance clinical and operational outcomes are contributing to the growth of the market. Augmented reality (AR) and virtual reality (VR)technologies are witnessing widespread adoption in surgical departments, simulation labs, education and training, and chronic pain management.

The rising number of complex surgeries is driving the demand for VR-based models to assist the surgeon. AR-based apps are used in multiple spaces such as training and education modules and patient care management tools. Innovators are receiving recognition in the form of increased investments by venture capitalists and collaboration opportunities by established players. For instance, in September 2020 OssoVR rose funding of USD 14.0 million and planned to utilize the funding towards developing virtual reality-based surgical and medical device training modules.

The hardware component segment witnessed the highest adoption owing to the rising adoption of AR and VR into different fields of healthcare. These devices range from desktops to wearable devices to display devices. Due to their audio-visual significance AR and VR is being widely adopted in education, simulation, telemedicine, and data visualization. Increasing product development in this space is contributing to market growth. For instance, in February 2019 Philips Healthcare launched a mixed reality solution by collaborating with Azurion and Microsoft. However, the services segment is expected to witness a significant CAGR during the forecast period owing to the growing need to create an immersive experience for the customer. The rising adoption in clinical trials, psychological treatment, advanced diagnostics, surgeries, and body mapping is expected to support market growth.

In addition, AR technological solutions are widely used in surgical procedures, fitness management, education and training, patient care management, medical imaging and is expected to be implemented in many more functionalities. Recent advancements in AR components have reduced the cost of augmented reality solutions and enhanced customer experience. The increasing prevalence of diseases and surgeries along with advancements in healthcare infrastructure and IT are some of the driving forces. Medical education and training using augmented reality technological solutions is also emerging rapidly and is expected to support growth. On the other hand, virtual reality technology is expected to be the fastest-growing region during the forecast period owing to the rapid integration of technology into healthcare services. VR technological solutions are widely used in telemedicine, anatomy visualization, and diagnostics. Additionally, it provides hands-on experience in medical education which is expected to contribute to market growth.

Request a free sample copy or view report summary: Augmented Reality & Virtual Reality In Healthcare Market Report

Augmented Reality & Virtual Reality In Healthcare Market Report Highlights

• The market is anticipated to grow well over the forecast period owing to the rapidly transforming and digitalization of the healthcare space
• Hardware component segment dominated the global augmented reality and virtual reality in healthcare market in 2020, owing to increased use in training, simulation, surgeries, and diagnostics
• The augmented reality technology segment dominated the market in 2020 owing to the growing adoption of inpatient care management, training and education, and medical imaging
• North America dominated the market in 2020 owing to sophisticated healthcare infrastructure and widespread awareness of the benefits of AR and VR in healthcare

Access Press Release@ https://www.grandviewresearch.com/press-release/global-augmented-reality-ar-virtual-reality-vr-in-healthcare-market

Augmented Reality & Virtual Reality In Healthcare Market Segmentation

Grand View Research has segmented the global augmented reality & virtual reality in healthcare market on the basis of component, technology, and region:

AR & VR In Healthcare Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software
• Service

AR & VR In Healthcare Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Augmented Reality
  • Surgical Application
  • Rehabilitation
  • Training and Medical Education
• Virtual Reality
  • Virtual Reality Exposure Therapy (VRET)
  • Simulation
  • Rehabilitation
  • Diagnostics
  • Pain Distraction

AR & VR In Healthcare Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Augmented Reality And Virtual Reality In Healthcare Market

• CAE
• GE Healthcare
• Koninklijke Philips N.V.
• Intuitive Surgical
• Siemens Ltd
• Eon Reality, Inc
• Layar
• Bioflight VR
• WorldViz
• TheraSim Inc
• Mindmaze

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.